New Advances

Parkinson’s Protein Fuels Melanoma

Summary New research reveals that alpha-synuclein, a protein linked to Parkinson’s disease, unexpectedly drives melanoma skin cancer. This discovery illuminates the complex relationship between neurological disorders and cancer, offering potential new therapeutic avenues for both. […]

New Advances

Elixir Launches IVL System

Summary Elixir Medical has launched its innovative LithiX™ Hertz Contact IVL System in Europe. This mechanical system uses focal stress points to fracture calcium in blood vessels, paving the way for more effective treatment of […]

New Advances

Gene’s Impact on Alzheimer’s

Summary New research suggests the PLXNB1 gene influences Alzheimer’s plaque size and toxicity, potentially offering new treatment avenues. This discovery sheds light on the role of glial cells in plaque formation and brain inflammation. Further […]

New Advances

ZEISS INTRABEAM 700: Robotic Precision

Summary The FDA has cleared ZEISS’s INTRABEAM 700, a robotic-assisted radiation therapy platform for neurooncology and breast cancer. This innovative system offers enhanced precision, streamlined workflows, and seamless connectivity, potentially revolutionizing cancer treatment. The platform’s […]

New Advances

Ultrasound Sees Cells

Summary Physicists develop groundbreaking ultrasound microscopy technique to visualize capillaries and cells in living organs, opening new possibilities for medical diagnoses and treatments. TrueNAS by Esdebe: healthcare data storage that delivers value without sacrificing security. […]

New Advances

Enovis Appoints New CEO

Summary Damien McDonald takes the helm at Enovis, succeeding Matt Trerotola. McDonald brings extensive medical device experience, previously serving as CEO of LivaNova. Enovis reaffirms its Q1 2025 financial guidance amid the leadership transition. Join […]

New Advances

A Safer Path to Pain Relief

Summary Researchers have identified a novel drug compound that activates pain-altering receptors, offering a safer alternative to conventional pain medications. This compound provides pain relief without the dangerous side effects commonly associated with opioids. This […]

New Advances

Biogen’s Alzheimer’s Drug Gets FDA Fast Track

Summary This article discusses Biogen’s experimental Alzheimer’s drug, BIIB080, receiving FDA Fast Track designation. The drug targets tau protein, a key factor in Alzheimer’s progression, and has shown promising results in early trials. This designation […]